Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Multi-omics and experimental analysis unveil theragnostic value and immunological roles of inner membrane mitochondrial protein (IMMT) in breast cancer

Fig. 3

IMMT expression according to clinical factors and pathological categories from multiple databases. A and B The Cancer Genomic Atlas (TCGA) repository-based IMMT expression levels. Box plot of IMMT expression according to clinical stages (A) and major subtypes (B). TPM, Transcripts Per Million. C–H SCAN-B (The Sweden Cancerome Analysis Network-Breast) repository-based IMMT expression levels. Violin plot of IMMT expression according to PAM subtypes (C), SBR (Scarff Bloom and Richardson) grade (D), IHC status of TNBC (triple-negative breast cancer) (E), nodal status (F), NPI (Nottingham prognostic index) (G) and IHC status of Ki67 (H). **p < 0.01, ***p < 0.001 when compared with normal group. N−, NPI1, or Ki67 low groups. #p < 0.05, ###p < 0.001 when comparing indicated groups

Back to article page